Non-tuberculous mycobacteria: new digital educational resource

Insmed, a global company focused on the unmet needs of patients with rare disease, has launched NTM Action, an interactive digital resource aiming to increase awareness of non-tuberculous mycobacteria (NTM) among UK healthcare professionals.

TalkingPoint completes all-remote installation at Royal Gwent Hospital

With social distancing restrictions in place, TalkingPoint has completed a rapid ‘all-remote’ deployment of the TalkingPoint Pathology speech-enabled histopathology reporting workflow at the Royal Gwent Hospital, Aneurin Bevan Health Board.

CytoSMART Technologies launches the CytoSMART Lux2 Duo Kit

CytoSMART Technologies has launched a new live-cell imaging system. The CytoSMART Lux2 Duo Kit offers a straightforward, cost-effective solution for researchers carrying out immediate side-by-side comparisons between cell cultures.

Point-of-care analysers help to keep vulnerable patients safer in Cornwall

HORIBA UK, Medical has announced that the Royal Cornwall Hospitals NHS Trust (RCHT) in partnership with the Cornwall Foundation NHS Trust has recently purchased and installed five new Microsemi CRP point-of-care (POC) haematology analysers.

Medica 2020: commitment to UK presence in November

With the unprecedented circumstances caused by the coronavirus pandemic, there have been a number of questions as to whether or not Medica, the largest medical technology exhibition in the world, will go ahead this year. Messe Düsseldorf, the organisers of Medica, are still planning for the show to take place on 16–19 November, with Medilink UK and GAMBICA being committed to organising UK pavilions at the exhibition.

Gap between non-tuberculous mycobacteria testing behaviour and guidelines identified

A study published in BMJ Open Respiratory Research has revealed that, contrary to guideline recommendations, 68% of clinicians managing bronchiectasis patients do not test them for non-tuberculous mycobacteria (NTM) infection prior to starting macrolide treatment.

Distribution agreement expands HbA1c POC testing to the Middle East and Africa

EKF Diagnostics has signed a three-year distribution agreement with Tosoh Europe for the distribution of its Quo-Test HbA1c point-of-care (POC) analyser in the Middle East and Africa.

Strategic alliance provides automated workflows for prostate cancer diagnostics

Proteomedix, the Swiss cancer diagnostics company, and Dynex Technologies have announced a strategic partnership enabling Proteomedix to establish automated workflows for its prostate cancer diagnostics test, and to sell Dynex instruments to the global clinical market.

Xdrop and single-molecule target selection of genomic regions

Samplix has launched its comprehensive service programme to grant any laboratory access to the advantages of Xdrop technology. By partnering with the Samplix service team, researchers can make use of the unique Xdrop approach to address complex genomic questions, including gap closing, sequencing of repeat elements, detecting viral insertion sites, revealing unintended CRISPR edits, and more.

Anti-certolizumab pegol inhibitory antibodies

Bio-Rad Laboratories has launched a range of anti-certolizumab pegol inhibitory antibodies to support the development of assays for therapeutic drug monitoring of tumour necrosis factor-alpha (TNFα) inhibitors.

Novel biomarker for cancer therapy: a webinar

Genomic instability is a universal hallmark of all cancers. Many common chemotherapeutic agents target this genomic instability by directly damaging the DNA, resulting in tumour cell death. A new generation of drugs have been developed that inhibit the DNA repair enzyme PARP to induce DNA damage. Dr Joshua Burgess (Advance Queensland Early Career Research Fellow at the Translational Research Institute, Queensland University of Technology) will be leading a free webinar on Tuesday 12 May (3.00 pm BST, 10.00 am EST, 7.00 am PST). Click on this story to access the link to register.

New point-of-care UTI technology to address antibiotic resistance

TTP, an independent technology and product development company, has partnered with ODx Innovations, a company committed to developing a system for assessing urinary tract infections (UTIs). The ODx system offers the potential to revolutionise the turnaround time for the assessment of suspected UTIs, reduce the use of antibiotics and provider faster access to optimal antimicrobial therapy.

Malaria mosquito research: insect control update

Scientists have discovered a malaria transmission-blocking microbe, which represents an important stride in the fight against the disease, reported in a study funded by Wellcome Trust and the UK GCRF Network ANTI-VeC.

Squalene-based nanoparticles in the treatment of septic shock and uncontrolled inflammation

Researchers from the Galien Institute at Paris-Saclay University/CNRS have developed nanoparticles that are effective in the treatment of severe inflammatory processes, which can be found in many pathologies, such as COVID-19. This research was published recently in the journal Science Advances.

Collaboration on automated digital cell morphology solution enhances workflows

HORIBA UK, Medical has introduced a new automated digital cell morphology solution in collaboration with CellaVision to help haematology laboratories simplify and expedite the performance of blood and body fluid differentials. CellaVision’s digital cell morphology systems can now be integrated with HORIBA’s HELO automated haematology platform, enabling two-way data flow and rapid validation of cell morphology results. These combined systems automate a number of steps that would otherwise be undertaken manually, significantly enhancing laboratory workflows and increasing productivity.

Pathologists and healthcare leaders urged to collaborate to transform cancer diagnostics

Leica Biosystems has launched The Future of Pathology Expert Report, which calls for pathologists and healthcare leaders to collaborate in pursuit of their common goal – to improve cancer diagnostics. Given the uncertain times currently faced by healthcare communities globally, The Future of Pathology Report details how the field of pathology can evolve to meet these challenges.

Breaking optical barriers to deliver outstanding image quality

Olympus has received a Gold Edison Award for its X Line objectives in the Applied Technology category and Optical & Imaging Technologies subcategory. The Edison Award is one of the most prestigious accolades honouring excellence in new product development, design and innovation.

Next-generation microscopy image analysis with deep-learning technology

Using the power of deep learning, Olympus cellSens imaging software for microscopy offers significantly improved segmentation analysis, such as label-free nucleus detection and cell counting, for more accurate data and efficient experiments.

Assisting leukaemia research at the UCL Cancer Institute

Researchers at the Cancer Institute, University College London (UCL), are using INTEGRA’s electronic pipette range to simplify workflows. Yvette Hoade (pictured), a research technician in the Payne Laboratory, Department of Haematology, is investigating mutations associated with various blood diseases such as bone marrow failure and myelodysplastic syndrome (MDS), both of which are age-related disorders that greatly increase the risk of developing leukaemia.

New App Launched: Pathology in Practice in action and on the move

Under the current lockdown conditions, keeping up to date with the very latest news, innovative technology and products in the biomedical science industry is easy. Pathology in Practice is now available via Apps free both in the Google Play Store and the Apple App Store. The App provides access to the current and previous digital issues of Pathology in Practice, together with copies of The Clinical Services Journal. Click on this news item to access the respective links.